General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Cardiff Oncology (CRDF) Stock Jumps 11.3%: Will It Continue to Soar? | news.google.com • |
Cardiff Oncology to Present at the Jefferies Healthcare Conference | globenewswire.com • |
Cardiff Oncology Inc (CRDF)'s Market Momentum: Closing Strong at 3.44, Up 4.24 – DWinneX | news.google.com • |
Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data | seekingalpha.com • |
Cardiff Oncology to Present at Upcoming Investor Conferences in May | globenewswire.com • |
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 | investorplace.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-02 | 2024-03 | -0.25 | -0.22 | 0.03 | 12.00% |
2024-02-29 | 2023-12 | -0.26 | -0.21 | 0.05 | 19.23% |
2023-11-02 | 2023-09 | -0.29 | -0.22 | 0.07 | 24.14% |
2023-08-09 | 2023-06 | -0.27 | -0.25 | 0.02 | 7.41% |
2023-05-04 | 2023-03 | -0.23 | -0.25 | -0.02 | -8.70% |
2023-03-02 | 2022-12 | -0.25 | -0.2 | 0.05 | 20.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-28 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-06 | HC Wainwright & Co. | Upgrade | Buy | |
2022-09-15 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-01-01 | ERLANDER MARK | Officer | 6.38K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.94M | 2.86M | 4.35% |
2023-06-29 | Blackrock Inc. | 760.27K | 1.12M | 1.70% |
2023-06-29 | Laurion Capital Management, LP | 722.10K | 1.06M | 1.62% |
2023-06-29 | Geode Capital Management, LLC | 381.15K | 560.29K | 0.85% |
2023-06-29 | Renaissance Technologies, LLC | 311.29K | 457.60K | 0.70% |
2023-06-29 | Gsa Capital Partners Llp | 296.68K | 436.12K | 0.66% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.29M | 1.89M | 2.88% |
2023-06-29 | Vanguard Extended Market Index Fund | 590.71K | 868.34K | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 205.72K | 331.21K | 0.46% |
2023-08-30 | iShares Micro Cap ETF | 89.53K | 164.74K | 0.20% |
2023-05-30 | Fidelity Total Market Index Fund | 75.26K | 121.17K | 0.17% |
2023-05-30 | Fidelity Series Total Market Index Fund | 48.44K | 77.99K | 0.11% |
Split | Date |
---|---|
1 : 6 | 2019-02-20 |
1 : 12 | 2018-06-04 |
1 : 6 | 2012-05-30 |
111 : 1 | 2004-07-27 |
Analyst Forecast
According to 11 analysts, the average rating for CRDF stock is "Buy." The 12-month stock price forecast is 12.92, which is an increase of 323.61% from the latest price.
Price Target
$12.92
(323.61% upside)
Analyst Consensus: Buy
Chart
Bar chart with 5 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 0 to 5.
Analyst Forecast
According to 11 analysts, the average rating for CRDF stock is "Buy." The 12-month stock price forecast is 12.92, which is an increase of 491.30% from the latest price.
Price Target
$12.92
(491.30% upside)
Analyst Consensus: Buy
Chart
Bar chart with 5 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 0 to 5.
Analyst Forecast
According to 12 analysts, the average rating for CRDF stock is "Buy." The 12-month stock price forecast is 12.92, which is an increase of 459.31% from the latest price.
Price Target
$12.92
(459.31% upside)
Analyst Consensus: Buy
Chart
Bar chart with 5 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 0 to 6.
StrongSell
Sell
Hold
Buy
StrongBuy
0
5
10
End of interactive chart.
Analyst Forecast
According to 12 analysts, the average rating for CRDF stock is "Buy." The 12-month stock price forecast is 12.92, which is an increase of 521.15% from the latest price.
Price Target
$12.92
(521.15% upside)
Analyst Consensus: Buy
Analyst Forecast
According to 12 analysts, the average rating for CRDF stock is "Buy." The 12-month stock price forecast is 15.3, which is an increase of 1,059.09% from the latest price.
Price Target
$15.3
(1,059.09% upside)
Analyst Consensus: Buy